Thanks for the update Dr! As per the NICE guidelines, andexanet alfa for reversing anticoagulation (by apixaban or rivaroxaban) is recommended for routine use only in gastrointestinal bleeding. It is recommended only in research in ICH. While, Idarucizumab (Praxbind®) is the Licensed reversal agent for dabigatran.
Very good video but the sound quality is not great
Thank you for free videos sir
We’re Glad you like them!
Thanks a lot sir
Andexanet alfa is the antodote of apixaban in Question 16 !
Thanks for the update Dr!
As per the NICE guidelines, andexanet alfa for reversing anticoagulation (by apixaban or rivaroxaban) is recommended for routine use only in gastrointestinal bleeding. It is recommended only in research in ICH.
While, Idarucizumab (Praxbind®) is the Licensed reversal agent for dabigatran.